Beurs gesloten -
Japan Exchange
08:00:00 14-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
371
JPY
|
-0,27%
|
|
+1,37%
|
-1,07%
|
19/03 |
Medical Net, Inc. (TSE:3645) en NU-DENT Co., Ltd. hebben de overname afgerond van Avision Co., Ltd. van Achievable Co., Ltd., AMBS Co., Ltd., Siriporn Phipatpongpan, Suchai Yenruedee, Kanokporn Pattanichanon, Thitiphat Chunkampanart, Khanchai Phatanaphanchai en anderen.
|
CI
| 05/01 |
Medical Net, Inc. (TSE:3645) heeft de overname afgerond van 12,1% van de aandelen van MiRTeL Co, Ltd van HC No. 8 Fund en High-Value C 1st Fund, beheerd door Hiroshima Venture Capital Co, Ltd., Furusato Renkei Ouen Fund, beheerd door Hiroshima Innovation Network Inc., Will Group Fund Investment Limited Partnership, beheerd door Future Venture Capital Co, Ltd. en 4 anderen.
|
CI
|
Fiscaal tijdperk: Mei |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
4.374
|
3.097
|
1.980
|
5.558
|
4.108
|
3.555
|
Bedrijfswaarde
1 |
3.101
|
2.146
|
1.785
|
5.072
|
3.748
|
2.826
|
K/w-verhouding
|
49,7
x
|
30,4
x
|
26,6
x
|
42,2
x
|
10,6
x
|
30,4
x
|
Dividendrendement
|
0,25%
|
0,35%
|
0,31%
|
0,39%
|
0,54%
|
0,64%
|
Marktkapitalisatie/omzet
|
2,51
x
|
1,39
x
|
0,68
x
|
1,67
x
|
1,1
x
|
0,79
x
|
Bedrijfswaarde/omzet
|
1,78
x
|
0,96
x
|
0,61
x
|
1,52
x
|
1
x
|
0,63
x
|
Bedrijfswaarde/EBITDA
|
18,6
x
|
11,1
x
|
14,3
x
|
14,3
x
|
7,83
x
|
6,42
x
|
Bedrijfswaarde/FCF
|
24,3
x
|
-24,7
x
|
63,7
x
|
15,4
x
|
21,5
x
|
7,6
x
|
FCF Yield
|
4,12%
|
-4,05%
|
1,57%
|
6,49%
|
4,66%
|
13,2%
|
Price to Book
|
2,83
x
|
1,9
x
|
1,99
x
|
4,48
x
|
2,41
x
|
1,86
x
|
Aantal aandelen (in duizenden)
|
10.773
|
10.773
|
8.081
|
8.618
|
8.816
|
9.045
|
Referentieprijs
2 |
406,0
|
287,5
|
245,0
|
645,0
|
466,0
|
393,0
|
Datum van publicatie
|
31-08-18
|
30-08-19
|
31-08-20
|
31-08-21
|
31-08-22
|
31-08-23
|
Fiscaal tijdperk: Mei |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1.740
|
2.236
|
2.917
|
3.330
|
3.745
|
4.500
|
EBITDA
1 |
167
|
194
|
125
|
355
|
479
|
440
|
Bedrijfsresultaat (EBIT)
1 |
153
|
176
|
106
|
331
|
450
|
379
|
Operationele Marge
|
8,79%
|
7,87%
|
3,63%
|
9,94%
|
12,02%
|
8,42%
|
Resultaat voor belastingen (EBT)
1 |
125
|
151
|
103
|
253
|
536
|
250
|
Nettowinst (verlies)
1 |
88
|
102
|
79
|
129
|
384
|
116
|
Nettomarge
|
5,06%
|
4,56%
|
2,71%
|
3,87%
|
10,25%
|
2,58%
|
WPA
2 |
8,169
|
9,468
|
9,214
|
15,28
|
43,88
|
12,95
|
Free Cash Flow
1 |
127,6
|
-87
|
28
|
329,2
|
174,6
|
372
|
FCF-marge
|
7,33%
|
-3,89%
|
0,96%
|
9,89%
|
4,66%
|
8,27%
|
Kasstroomconversie (ebitda)
|
76,42%
|
-
|
22,4%
|
92,75%
|
36,46%
|
84,55%
|
Kasstroomconversie (nettowinst)
|
145,03%
|
-
|
35,44%
|
255,23%
|
45,48%
|
320,69%
|
Dividend per aandeel
2 |
1,000
|
1,000
|
0,7500
|
2,500
|
2,500
|
2,500
|
Datum van publicatie
|
31-08-18
|
30-08-19
|
31-08-20
|
31-08-21
|
31-08-22
|
31-08-23
|
Fiscaal tijdperk: Mei |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Omzet
1 |
-
|
1.592
|
1.702
|
889
|
971
|
1.997
|
1.128
|
1.099
|
2.342
|
1.313
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
180
|
249
|
126
|
92
|
192
|
68
|
22
|
169
|
62
|
Operationele Marge
|
-
|
11,31%
|
14,63%
|
14,17%
|
9,47%
|
9,61%
|
6,03%
|
2%
|
7,22%
|
4,72%
|
Resultaat voor belastingen (EBT)
1 |
-
|
127
|
328
|
129
|
103
|
221
|
26
|
44
|
192
|
-34
|
Nettowinst (verlies)
1 |
-
|
65
|
246
|
86
|
57
|
130
|
9
|
21
|
115
|
-69
|
Nettomarge
|
-
|
4,08%
|
14,45%
|
9,67%
|
5,87%
|
6,51%
|
0,8%
|
1,91%
|
4,91%
|
-5,26%
|
WPA
2 |
-
|
7,865
|
28,42
|
9,640
|
6,520
|
14,74
|
0,8700
|
2,410
|
12,80
|
-7,670
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
-
|
12-01-21
|
12-01-22
|
14-04-22
|
14-10-22
|
13-01-23
|
14-04-23
|
13-10-23
|
12-01-24
|
12-04-24
|
Fiscaal tijdperk: Mei |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.273
|
951
|
195
|
486
|
360
|
729
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
128
|
-87
|
28
|
329
|
175
|
372
|
ROE (netto-inkomsten/eigen vermogen)
|
4,89%
|
6,39%
|
6,28%
|
12,1%
|
26,6%
|
5,95%
|
ROA (netto-inkomsten/totale activa)
|
5,23%
|
5,59%
|
3,5%
|
10,8%
|
10,7%
|
7,16%
|
Totale activa
1 |
1.682
|
1.824
|
2.258
|
1.198
|
3.592
|
1.621
|
Nettoactief per aandeel
2 |
143,0
|
152,0
|
123,0
|
144,0
|
194,0
|
212,0
|
Cashflow per aandeel
2 |
118,0
|
96,70
|
74,90
|
101,0
|
129,0
|
168,0
|
Capex
1 |
5
|
19
|
8
|
13
|
2
|
19
|
Capex/omzet
|
0,29%
|
0,85%
|
0,27%
|
0,39%
|
0,05%
|
0,42%
|
Datum van publicatie
|
31-08-18
|
30-08-19
|
31-08-20
|
31-08-21
|
31-08-22
|
31-08-23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -1,07% | 21,54 mln. | | +18,07% | 83,07 mld. | | -29,60% | 70,89 mld. | | +3,59% | 28,32 mld. | | -7,77% | 17,73 mld. | | +2,00% | 17,43 mld. | | +0,75% | 15,64 mld. | | +7,55% | 13,46 mld. | | +7,64% | 12,82 mld. | | +69,41% | 12,69 mld. |
Gezondheidszorgvoorzieningen & -diensten - Andere
|